HK1206990A1 - Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole - Google Patents

Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Info

Publication number
HK1206990A1
HK1206990A1 HK15107666.1A HK15107666A HK1206990A1 HK 1206990 A1 HK1206990 A1 HK 1206990A1 HK 15107666 A HK15107666 A HK 15107666A HK 1206990 A1 HK1206990 A1 HK 1206990A1
Authority
HK
Hong Kong
Prior art keywords
aripiprazole
solid preparation
oral solid
producing
producing oral
Prior art date
Application number
HK15107666.1A
Other languages
Chinese (zh)
Inventor
Haruka Yoshida
Toshiaki Taniguchi
Tadashi Mukai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50897828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1206990(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1206990A1 publication Critical patent/HK1206990A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107666.1A 2013-04-30 2015-08-08 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole HK1206990A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013095725 2013-04-30
JP2013204546 2013-09-30
PCT/JP2014/061643 WO2014178334A1 (en) 2013-04-30 2014-04-18 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Publications (1)

Publication Number Publication Date
HK1206990A1 true HK1206990A1 (en) 2016-01-22

Family

ID=50897828

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107666.1A HK1206990A1 (en) 2013-04-30 2015-08-08 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Country Status (11)

Country Link
EP (2) EP3187173A1 (en)
JP (1) JP5931219B2 (en)
KR (2) KR101759017B1 (en)
CN (1) CN105246461B (en)
AU (2) AU2014260863A1 (en)
CA (1) CA2910665C (en)
ES (1) ES2625613T3 (en)
HK (1) HK1206990A1 (en)
PH (1) PH12015502435B1 (en)
TW (2) TWI624276B (en)
WO (1) WO2014178334A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2608788B2 (en) 1988-10-31 1997-05-14 大塚製薬 株式会社 Schizophrenia remedy
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
AR033485A1 (en) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME
ES2315721T5 (en) * 2003-10-23 2012-08-24 Otsuka Pharmaceutical Co., Ltd. Formulation of sterile controlled-release injectable aripiprazole and procedure
EP1933814A2 (en) * 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
EP1919453A2 (en) * 2005-12-22 2008-05-14 Teva Pharmaceutical Industries Ltd Processes for reducing particle size of aripiprazole
PL1808164T3 (en) * 2006-01-05 2009-06-30 Teva Pharma Wet granulation method for preparing pharmaceutical compositions of aripiprazole
TR200604349A2 (en) * 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Pharmaceutical compositions containing aripiprazole
KR100924236B1 (en) * 2009-06-23 2009-10-29 충남대학교산학협력단 Methods and apparatus for preparing ultra-fine particles with narrow particle size distribution
CN102106807B (en) * 2009-12-29 2013-03-27 上海中西制药有限公司 Method for preparing solid preparation and solid preparation
US9241876B2 (en) * 2011-06-27 2016-01-26 Shanghai Zhongxi Pharmaceutical Corporation Aripiprazole medicament formulation and preparation method therefor
CN102850268B (en) * 2011-06-27 2015-07-15 上海中西制药有限公司 Aripiprazole I-type crystallite, aripiprazole solid preparation and preparation methods thereof
TW201309651A (en) * 2011-06-29 2013-03-01 Otsuka Pharma Co Ltd Method for producing fine particles of aripiprazole anhydride crystals B

Also Published As

Publication number Publication date
PH12015502435A1 (en) 2016-02-22
KR101759017B1 (en) 2017-07-17
CN105246461A (en) 2016-01-13
WO2014178334A1 (en) 2014-11-06
EP2838513A1 (en) 2015-02-25
TW201740947A (en) 2017-12-01
CA2910665A1 (en) 2014-11-06
TW201521793A (en) 2015-06-16
CA2910665C (en) 2018-05-22
JP5931219B2 (en) 2016-06-08
ES2625613T3 (en) 2017-07-20
JP2015516942A (en) 2015-06-18
KR20160003136A (en) 2016-01-08
AU2014260863A2 (en) 2015-12-17
EP3187173A1 (en) 2017-07-05
PH12015502435B1 (en) 2016-02-22
AU2014260863A1 (en) 2015-11-05
AU2017204483A1 (en) 2017-07-20
CN105246461B (en) 2018-03-30
AU2017204483B2 (en) 2019-04-04
EP2838513B1 (en) 2017-04-05
KR20170052704A (en) 2017-05-12
TWI624276B (en) 2018-05-21

Similar Documents

Publication Publication Date Title
HK1221720A1 (en) Quinazoline derivative and preparation method therefor
EP2945678A4 (en) Patient interface and method for making same
EP2945680A4 (en) Patient interface and method for making same
EP3071276A4 (en) Patient interface and method for making same
EP3006415B8 (en) Method for producing nanocement and nanocement
EP3031353C0 (en) Oral care system and method
SG11201500606UA (en) Patient interface and method for making same
EP2967771A4 (en) System and process for manufacturing of dentures
IL244285A0 (en) Methods for preparing edible compositions and edible compositions produced thereby
SG11201505498YA (en) Method for preparing polybutene
EP3006058A4 (en) Blood filter and method for producing same
PL3040074T3 (en) Injection preparation and method for producing same
EP2980084A4 (en) Method for producing glycolide
HK1224221A1 (en) Solid preparation comprising tofogliflozin and method for producing same
HK1202857A1 (en) Benzodioxole derivative and preparation method and use thereof
EP2982843A4 (en) Shield and method for producing shield
HK1206329A1 (en) Phenol derivative, method of preparing same, and pharmaceutical application of same
EP2952519A4 (en) Protopanoxadiol derivative, preparation method thereof and application thereof
IL239958A0 (en) Chewable composition for oral administration and process for preparing thereof
PL3069610T3 (en) Co-crystal and method for producing same
EP3051131A4 (en) Compressor and method for producing compressor
EP2837624A4 (en) 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
PL3062628T3 (en) Improved chewing gums and methods for their preparation
EP2980083A4 (en) Method for producing glycolide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210414